Polyclonal Spread of Fosfomycin Resistance among Carbapenemase-Producing Members of the Enterobacterales in the Czech Republic
ABSTRACT Fosfomycin (FOS) has been recently reintroduced into clinical practice, but its effectiveness against multidrug-resistant (MDR) Enterobacterales is reduced due to the emergence of FOS resistance. The copresence of carbapenemases and FOS resistance could drastically limit antibiotic treatmen...
| Published in: | Microbiology Spectrum |
|---|---|
| Main Authors: | V. Mattioni Marchetti, L. Kraftova, M. Finianos, T. Sourenian, J. Hrabak, I. Bitar |
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2023-06-01
|
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/spectrum.00095-23 |
Similar Items
Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat
by: Vittoria Mattioni Marchetti, et al.
Published: (2023-07-01)
by: Vittoria Mattioni Marchetti, et al.
Published: (2023-07-01)
Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant Enterobacterales in Egypt: A Cross-Sectional Study
by: Shrief R, et al.
Published: (2022-10-01)
by: Shrief R, et al.
Published: (2022-10-01)
Implication of different replicons in the spread of the VIM-1-encoding integron, In110, in Enterobacterales from Czech hospitals
by: Ibrahim Bitar, et al.
Published: (2023-01-01)
by: Ibrahim Bitar, et al.
Published: (2023-01-01)
Carbapenemase-Producing Enterobacterales from Patients Arriving from Ukraine in Poland, March 2022–February 2023
by: Marta Biedrzycka, et al.
Published: (2025-01-01)
by: Marta Biedrzycka, et al.
Published: (2025-01-01)
Differences in antimicrobial susceptibility testing complicating management of IMP carbapenemase-producing Enterobacterales infection
by: C. Hickey, et al.
Published: (2021-12-01)
by: C. Hickey, et al.
Published: (2021-12-01)
Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia
by: Alice Ying-Jung Wu, et al.
Published: (2022-12-01)
by: Alice Ying-Jung Wu, et al.
Published: (2022-12-01)
Blood-rsCDM: a new rapid and simplified carbapenemase detection method for detecting carbapenemases in Enterobacterales directly from positive blood cultures
by: Quanfeng Liao, et al.
Published: (2024-10-01)
by: Quanfeng Liao, et al.
Published: (2024-10-01)
Diminishment of Carbapenemase-Producing Enterobacterales from Sink Outlets Using a Steam Cleaner
by: Takumi Umemura, et al.
Published: (2023-01-01)
by: Takumi Umemura, et al.
Published: (2023-01-01)
FosA3 emerging in clinical carbapenemase-producing C. freundii
by: Vittoria Mattioni Marchetti, et al.
Published: (2024-08-01)
by: Vittoria Mattioni Marchetti, et al.
Published: (2024-08-01)
Gastrointestinal carriage of carbapenemase-producing enterobacterales among inpatient and outpatient children in Kenya
by: Susan Githii, et al.
Published: (2024-12-01)
by: Susan Githii, et al.
Published: (2024-12-01)
Infectious complications caused by carbapenemase-producing Enterobacterales in patients with hematological disorders
by: K. S. Tandilova, et al.
Published: (2019-10-01)
by: K. S. Tandilova, et al.
Published: (2019-10-01)
Clinical and Demographic Characteristics of Patients With a New Diagnosis of Carriage or Clinical Infection With Carbapenemase-Producing Enterobacterales: A Retrospective Study
by: Assaf Adar, et al.
Published: (2021-02-01)
by: Assaf Adar, et al.
Published: (2021-02-01)
Risk factors associated with colistin resistance in carbapenemase-producing Enterobacterales: a multicenter study from a low-income country
by: Soria-Segarra Claudia, et al.
Published: (2023-08-01)
by: Soria-Segarra Claudia, et al.
Published: (2023-08-01)
Clinical, microbiological characteristics and outcomes of carbapenemase-producing enterobacterales bloodstream infections in a pediatric hospital in Brazil
by: Derrick A. Fassbind, et al.
Published: (2025-10-01)
by: Derrick A. Fassbind, et al.
Published: (2025-10-01)
Risk Factors for Non-Carbapenemase-Producing Carbapenem-Resistant <i>Enterobacterales</i> Infections: A Retrospective Cohort Study
by: Sayaka Mabuchi, et al.
Published: (2025-05-01)
by: Sayaka Mabuchi, et al.
Published: (2025-05-01)
Model-based evaluation of admission screening strategies for the detection and control of carbapenemase-producing Enterobacterales in the English hospital setting
by: Diane Pople, et al.
Published: (2023-12-01)
by: Diane Pople, et al.
Published: (2023-12-01)
The evolving epidemiology of Carbapenemase-producing Enterobacterales in Canadian acute care facilities, 2010–2023
by: Robyn Mitchell, et al.
Published: (2025-07-01)
by: Robyn Mitchell, et al.
Published: (2025-07-01)
Evaluation of Xpert Carba-R for detecting carbapenemase-producing organisms in South Africa
by: Sanelisiwe T. Duze, et al.
Published: (2023-01-01)
by: Sanelisiwe T. Duze, et al.
Published: (2023-01-01)
Screening sites for detection of carbapenemase-producers– a retrospective cohort study
by: Isabelle Vock, et al.
Published: (2024-12-01)
by: Isabelle Vock, et al.
Published: (2024-12-01)
Understanding the landscape of carbapenemase-producing organisms (CPOs), and spotlighting opportunities for control in England
by: Akaninyene Otu, et al.
Published: (2025-12-01)
by: Akaninyene Otu, et al.
Published: (2025-12-01)
Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study
by: Lidia Kardaś-Słoma, et al.
Published: (2022-09-01)
by: Lidia Kardaś-Słoma, et al.
Published: (2022-09-01)
The impact of enhanced screening for carbapenemase-producing Enterobacterales in an acute care hospital in South Korea
by: Sun Hee Park, et al.
Published: (2023-07-01)
by: Sun Hee Park, et al.
Published: (2023-07-01)
An Economic Model to Assess the Cost Impact of Using Xpert Carba-R to Screen Carbapenemase-Producing Enterobacterales in Comparison with Standard of Care, in a National Health Service Setting
by: Mondher Toumi, et al.
Published: (2025-04-01)
by: Mondher Toumi, et al.
Published: (2025-04-01)
Emergence and Spread of Enterobacterales with Multiple Carbapenemases after COVID-19 Pandemic
by: Branka Bedenić, et al.
Published: (2023-05-01)
by: Branka Bedenić, et al.
Published: (2023-05-01)
Knowledge, attitudes and self-reported practices of healthcare professionals on Carbapenemase Producing Enterobacterales (CPE): A cross sectional study
by: Shaini Paul Mathew, et al.
Published: (2023-03-01)
by: Shaini Paul Mathew, et al.
Published: (2023-03-01)
In Vitro Activity of Aztreonam-avibactam and Comparator Agents Against Carbapenemase-producing Enterobacterales Collected in Turkey and the Middle East as Part of the ATLAS Surveillance Program: 2018-2022
by: Mark Estabrook, et al.
Published: (2024-12-01)
by: Mark Estabrook, et al.
Published: (2024-12-01)
Characterization of carbapenemase-producing Enterobacterales from rectal swabs of patients in the intensive care units of a tertiary hospital in Cali-Colombia
by: Mónica Fernandes-Pineda, et al.
Published: (2024-06-01)
by: Mónica Fernandes-Pineda, et al.
Published: (2024-06-01)
Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales
by: Kévin Bouiller, et al.
Published: (2022-02-01)
by: Kévin Bouiller, et al.
Published: (2022-02-01)
Polyclonal carbapenemase-producing Escherichia coli in Northern Italy: the emergence of NDM-7
by: Vittoria Mattioni Marchetti, et al.
Published: (2025-03-01)
by: Vittoria Mattioni Marchetti, et al.
Published: (2025-03-01)
Performance Evaluation of BD Phoenix and MicroScan WalkAway Plus for Determination of Fosfomycin Susceptibility in <i>Enterobacterales</i>
by: Alessandro Bondi, et al.
Published: (2023-06-01)
by: Alessandro Bondi, et al.
Published: (2023-06-01)
Clonal spread of carbapenemase-producing Enterobacteriaceae in a region, China
by: Changfu Yin, et al.
Published: (2022-03-01)
by: Changfu Yin, et al.
Published: (2022-03-01)
Efficacy of high doses of intravenous fosfomycin for treatment of urinary tract infection caused by KPC carbapenemase-producing Klebsiella pneumoniae: An observational study
by: Jorge Rodríguez-Gómez, et al.
Published: (2025-03-01)
by: Jorge Rodríguez-Gómez, et al.
Published: (2025-03-01)
Fosfomycin susceptibility testing and resistance mechanisms in Enterobacterales in South Africa
by: Jessica S. Hurwitz, et al.
Published: (2024-03-01)
by: Jessica S. Hurwitz, et al.
Published: (2024-03-01)
Detection of Extended-Spectrum β-Lactamases (ESBLs) and AmpC in Class A and Class B Carbapenemase-Producing Enterobacterales
by: Frank Imkamp, et al.
Published: (2022-12-01)
by: Frank Imkamp, et al.
Published: (2022-12-01)
New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria
by: Yancheng Yao, et al.
Published: (2022-01-01)
by: Yancheng Yao, et al.
Published: (2022-01-01)
Clinical, microbiological characteristics and predictors of mortality in patients with carbapenemase-producing Enterobacterales bloodstream infections: a multicentre study
by: Vanesa Anton-Vazquez, et al.
Published: (2023-09-01)
by: Vanesa Anton-Vazquez, et al.
Published: (2023-09-01)
Differences in the Distribution of Species, Carbapenemases, Sequence Types, Antimicrobial Heteroresistance and Mortality Rates Between Pediatric and Adult Carbapenemase-Producing Enterobacterales in Bloodstream Infections
by: Hanbing Yu, et al.
Published: (2022-03-01)
by: Hanbing Yu, et al.
Published: (2022-03-01)
Evaluation of the in vitro efficacy of antimicrobials against Enterobacterales with multiple carbapenemase enzymes
by: Reena Rajan, et al.
Published: (2025-06-01)
by: Reena Rajan, et al.
Published: (2025-06-01)
Risk Factors for Carbapenemase-Producing <i>Enterobacterales</i> Infection or Colonization in a Korean Intensive Care Unit: A Case–Control Study
by: Young Ah Kim, et al.
Published: (2020-10-01)
by: Young Ah Kim, et al.
Published: (2020-10-01)
Transmission of global clones of NDM-producing Enterobacterales and interspecies spread of IncX3 plasmid harbouring blaNDM-5 in Tokyo
by: Sohei Harada, et al.
Published: (2024-09-01)
by: Sohei Harada, et al.
Published: (2024-09-01)
Similar Items
-
Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat
by: Vittoria Mattioni Marchetti, et al.
Published: (2023-07-01) -
Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant Enterobacterales in Egypt: A Cross-Sectional Study
by: Shrief R, et al.
Published: (2022-10-01) -
Implication of different replicons in the spread of the VIM-1-encoding integron, In110, in Enterobacterales from Czech hospitals
by: Ibrahim Bitar, et al.
Published: (2023-01-01) -
Carbapenemase-Producing Enterobacterales from Patients Arriving from Ukraine in Poland, March 2022–February 2023
by: Marta Biedrzycka, et al.
Published: (2025-01-01) -
Differences in antimicrobial susceptibility testing complicating management of IMP carbapenemase-producing Enterobacterales infection
by: C. Hickey, et al.
Published: (2021-12-01)
